Psychiatry Research
Volume 135, Issue 1 , Pages 65-75 , 15 May 2005

Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies

  • Michael Ritsner

      Affiliations

    • Pathological Behavior and Psychobiology Research Laboratory, Sha'ar Menashe Mental Health Center, Hadera, Israel
    • Department of Psychiatry, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
    • Corresponding Author InformationCorresponding author. Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Israel. Tel.: +972 4 6278750; fax: +972 4 6278045.
  • ,
  • Rena Kurs

      Affiliations

    • Pathological Behavior and Psychobiology Research Laboratory, Sha'ar Menashe Mental Health Center, Hadera, Israel
  • ,
  • Yael Ratner

      Affiliations

    • Pathological Behavior and Psychobiology Research Laboratory, Sha'ar Menashe Mental Health Center, Hadera, Israel
  • ,
  • Anatoly Gibel

      Affiliations

    • Pathological Behavior and Psychobiology Research Laboratory, Sha'ar Menashe Mental Health Center, Hadera, Israel

Received 13 April 2004 ,Revised 26 December 2004 ,Accepted 15 January 2005.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: APA; 1994;
  2. Andrich D. Controversy and the Rasch model: a characteristic of incompatible paradigms?. Medical Care. 2004;42(1 Suppl.):16–17
  3. Angermeyer MC, Holzinger A, Kilian R, Matschinger H. Quality of life—as defined by schizophrenic patients and psychiatrists. International Journal of Social Psychiatry. 2001;47:34–42
  4. Awad AG, Voruganti LN. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophrenia Bulletin. 2000;26:557–564
  5. Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology. 2003;28:773–777
  6. Bjorner JB, Kosinski M, Ware JE. Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales. Quality of Life Research. 2003;12:981–1002
  7. Bow-Thomas CC, Velligan DI, Miller AL, Olsen J. Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Research. 1999;86:131–142
  8. Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophrenia Bulletin. 2001;27:697–708
  9. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica. 1996;94:118–124
  10. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. British Journal of Psychiatry. 2000;176:173–176
  11. Bryson G, Lysaker P, Bell M. Quality of life benefits of paid work activity in schizophrenia. Schizophrenia Bulletin. 2002;28:249–257
  12. Chouinard G, Ross-Chouinard A, Annale L, Jones BD. Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Sciences. 1980;7:233
  13. Cramer JA, Rosenheck R, Xu W, Thomas J, Henderson W, Charney DS. Quality of life in schizophrenia: a comparison of instruments. Schizophrenia Bulletin. 2000;26:659–666
  14. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin. 1993;29:321–326
  15. Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adams A, et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica. 2001;103:387–392
  16. Gaite L, Vazquez-Barquero JL, Borra C, Ballesteros J, Schene A, Welcher B, et al. Quality of life in patients with schizophrenia in five European countries: the EPSILON study. Acta Psychiatrica Scandinavica. 2002;105:283–292
  17. Gureje O, Miles W, Keks N, Grainger D, Lambert T, McGrath J, et al. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophrenia Research. 2003;61:303–314
  18. Hamilton SH, Revicki DA, Edgell ET, Genduso LA, Tollefson G. Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial. Pharmacoeconomics. 1999;15:469–480
  19. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin. 1984;10:388–398
  20. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neuroscience. 1997;22:235–243
  21. Hintze JL. NCSS 6.0. Statistical System for Windows. User's Guide. Kaysville, Utah: Number Cruncher Statistical Systems; 1998;
  22. Kaneda Y, Ohmori T. Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation. International Journal of Neuropsychopharmacology. 2003;6:247–252
  23. Kaneda Y, Imakura A, Fujii A, Ohmori T. Schizophrenia Quality of Life Scale: validation of the Japanese version. Psychiatry Research. 2002;113:107–113
  24. Katschnig H. How useful is the concept of quality of life in psychiatry?. Current Opinion in Psychiatry. 1997;10:337–345
  25. Katschnig H. Schizophrenia and quality of life. Acta Psychiatrica Scandinavica Supplementum. 2000;102:33–37
  26. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261–276
  27. Kemmler G, Meise U, Tasser A. Subjective quality of life of schizophrenic patients. Effect of treatment setting, psychopathology and extrapyramidal motor drug effects. Psychiatrische Praxis. 1999;26:9–15
  28. Lançon C, Auquier P, Launois R, Toumi M, Llorca PM, Bebbington P, et al. Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview. Encephale. 2000;26:11–16
  29. Lasalvia A, Ruggeri M, Santolini N. Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6. Psychotherapy and Psychosomatics. 2002;71:275–284
  30. Lindeboom R, Holman R, Dijkgraaf MG, Sprangers MA, Buskens E, Diederiks JP, et al. Scaling the Sickness Impact Profile using item response theory: an exploration of linearity, adaptive use, and patient driven item weights. Clinical Epidemiology. 2004;57:66–74
  31. Lobana A, Mattoo SK, Basu D, Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatrica Scandinavica. 2001;104:51–55
  32. McHorney CA, Haley SM, Ware JE. Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. Journal of Clinical Epidemiology. 1997;50:451–461
  33. Montes JM, Ciudad A, Gascon J, Gomez JC. EFESO Study Group. Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2003;27:667–674
  34. Noerholm V, Groenvold M, Watt T, Bjorner JB, Rasmussen NA, Bech P. Quality of life in the Danish general population-normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Quality of Life Research. 2004;13:531–540
  35. Rijmen F, Tuerlinckx F, De Boeck P, Kuppens P. A nonlinear mixed model framework for item response theory. Psychological Methods. 2003;8:185–205
  36. Ritsner M, Kurs R. Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research. 2002;2:89–98
  37. Ritsner M, Kurs R. Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders. Expert Review of Pharmacoeconomics & Outcomes Research. 2003;3:189–199
  38. Ritsner M, Rabinowitz J, Slyuzberg M. The Talbieh Brief Distress Inventory: a brief instrument to measure psychological distress among immigrants. Comprehensive Psychiatry. 1995;36:448–453
  39. Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. Journal of Clinical Psychiatry. 2000;61:880–889
  40. Ritsner M, Modai I, Ponizovsky A. Assessing psychological distress in psychiatric patients: validation of the Talbieh Brief Distress Inventory. Comprehensive Psychiatry. 2002;43:229–234
  41. Ritsner M, Ponizovsky A, Endicott J, Nechamkin Y, Rauchverger B, Silver H, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. European Neuropsychopharmacology. 2002;12:31–38
  42. Ritsner M, Perelroyzen G, Ilan H, Gibel A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. International Clinical Psychopharmacology. 2004;24:245–254
  43. Ruggeri M, Bisoffi G, Fontecedro L, Warner R. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: the South Verona Outcome Project 4. British Journal of Psychiatry. 2001;178:268–275
  44. Simon-Abbadi S, Guelfi JD, Ginestet D. Psychometric qualities of the French version of the Heinrichs Quality of Life Rating Scale. European Psychiatry. 1999;14:386–391
  45. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology. 1997;30:263–274
  46. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine. 1998;28:551–558

PII: S0165-1781(05)00063-6

doi: 10.1016/j.psychres.2005.01.007

Psychiatry Research
Volume 135, Issue 1 , Pages 65-75 , 15 May 2005